For example, TIGIT–CD112 axis has recently been identified as an important factor that influences immunity against tumor in neuroblastoma [44], although CD112 has a higher affinity for CD112R and has been considered as another axis in immunotherapy [22, 23]. This evidence concerns the gene NECTIN2 and neuroblastoma.